Evidence map›Paper›PMID 33918053›Full record

ArticleInternational journal of molecular sciences2021

Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration.

Vittorio Abruzzese, Ilenia Matera, Fabio Martinelli, Monica Carmosino, Prashant Koshal, Luigi Milella, Faustino Bisaccia, Angela Ostuni

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  9. Health Benefits of Quercetin in Age-Related Diseases.Molecules (Basel, Switzerland) · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Vittorio AbruzzeseDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Ilenia MateraDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Fabio MartinelliDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Monica CarmosinoDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Prashant KoshalDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Luigi MilellaDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0002-5874-1237
Faustino BisacciaDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Angela OstuniDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0001-5970-5097
University of Basilicata · IT

Funding

INBIOMED PROJECT (MIUR, ARS01_01081). INBIOMED PROJECT (MIUR, ARS01_01081).
6 · The paper itself

Abstract

Quercetin is a member of the flavonoid group of compounds, which is abundantly present in various dietary sources. It has excellent antioxidant properties and anti-inflammatory activity and is very effective as an anti-cancer agent against various types of tumors, both in vivo and in vitro. Quercetin has been also reported to modulate the activity of some members of the multidrug-resistance transporters family, such as P-gp, ABCC1, ABCC2, and ABCG2, and the activity of ecto-5'-nucleotidase (NT5E/CD73), a key regulator in some tumor processes such as invasion, migration, and metastasis. In this study, we investigated the effect of Quercetin on ABCC6 expression in HepG2 cells. ABCC6 is a member of the superfamily of ATP-binding cassette (ABC) transporters, poorly involved in drug resistance, whose mutations cause pseudoxanthoma elasticum, an inherited disease characterized by ectopic calcification of soft connective tissues. Recently, it has been reported that ABCC6 contributes to cytoskeleton rearrangements and HepG2 cell motility through purinergic signaling. Gene and protein expression were evaluated by quantitative Reverse-Transcription PCR (RT-qPCR) and western blot, respectively. Actin cytoskeleton dynamics was evaluated by laser confocal microscopy using fluorophore-conjugated phalloidin. Cell motility was analyzed by an in vitro wound-healing migration assay. We propose that ABCC6 expression may be controlled by the AKT pathway as part of an adaptative response to oxidative stress, which can be mitigated by the use of Quercetin-like flavonoids.

Indexed as

ActinsATP-Binding Cassette, Sub-Family C ProteinsCell MovementCell SurvivalDrug Resistance, MultipleDrug Resistance, NeoplasmGene Expression RegulationHep G2 CellsHumansIon Channel GatingMultidrug Resistance-Associated Protein 2Protein MultimerizationQuercetinReactive Oxygen SpeciesSignal TransductionABCC2 protein, humanABCC6 protein, humanActinsATP-Binding Cassette, Sub-Family C ProteinsMultidrug Resistance-Associated Protein 2QuercetinReactive Oxygen SpeciesABCC6cell migrationcytoskeletonHepG2PI3K/AKT signalingquercetin

Identifiers

PMID33918053
PMCPMC8069417
OpenAlexW3144086682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.